Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing Its Solubility and Permeability1
- 1 January 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (12) , 1812-1817
- https://doi.org/10.1023/a:1018939006780
Abstract
Purpose. To investigate the effect of vitamin E-TPGS, d-α-tocopheryl polyethylene glycol 1000 succinate, on the solubility and permeability of amprenavir, a potent HIV protease inhibitor. Methods....Keywords
This publication has 14 references indexed in Scilit:
- Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line.1998
- AmprenavirDrugs, 1998
- Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug deliveryAdvanced Drug Delivery Reviews, 1997
- Mechanistic Roles of Neutral Surfactants on Concurrent Polarized and Passive Membrane Transport of a Model Peptide in Caco-2 CellsJournal of Pharmaceutical Sciences, 1997
- The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers*Clinical Pharmacology & Therapeutics, 1996
- Age-dependent Expression of P-Glycoprotein gp17O in Caco-2 Cell MonolayersPharmaceutical Research, 1996
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995
- Multicenter trial of d-α-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasisGastroenterology, 1993
- Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin EThe Lancet, 1991
- Theoretical and Experimental Studies of Transport of Micelle-Solubilized SolutesJournal of Pharmaceutical Sciences, 1982